Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis
Autor: | Salvatore De Vita, Marco Binutti, Giulia Del Frate, Luca Quartuccio, Elena Treppo |
---|---|
Rok vydání: | 2021 |
Předmět: |
2019-20 coronavirus outbreak
biology Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) MEDLINE ANCA-Associated Vasculitis Rheumatology Immunology biology.protein medicine Pharmacology (medical) Rituximab Risk of death Antibody business medicine.drug |
Zdroj: | Rheumatology. |
ISSN: | 1462-0332 1462-0324 |
Databáze: | OpenAIRE |
Externí odkaz: |